Published • loading... • Updated
Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk
Summary by aboutlawsuits.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk
Researchers are calling on doctors to monitor patients taking GLP-1s, to watch for early signs of non-arteritic anterior ischemic optic neuropathy (NAION). A new study provides more evidence that side effects of diabetes and weight loss drugs like Ozempic and Wegovy may cause a rare eye condition, which results in sudden and possibly permanent vision lo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
